Cancer Patient Care during COVID-19

Harky, Amer; Chiu, Chun Ming; Yau, Thomas Ho Lai; Lai, Sheung Heng Daniel

doi:10.1016/j.ccell.2020.05.006

Cited by 56 publications

(53 citation statements)

References 10 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Along these lines, during the SARS-CoV-2 pandemic, cancer screenings and non-emergency in-person visits of new patients were frequently declined for the sake of epidemiological infectious disease control. 12 Similar to previous studies in other medical specialties, our patients were highly satisfied with their video call experience. 3 6 13 Reasons for high patient satisfaction may be the observed cost and times savings, which were similar to previous reports.…”

Section: Discussionsupporting

confidence: 85%

Completion rate and impact on physician–patient relationship of video consultations in medical oncology: a randomised controlled open-label trial

et al. 2020

View full text Add to dashboard Cite

BackgroundMobile phone video call applications generally did not undergo testing in randomised controlled clinical trials prior to their implementation in patient care regarding the rate of successful patient visits and impact on the physician–patient relationship.MethodsThe National Center for Tumour Diseases (NCT) MOBILE trial was a monocentric open-label randomised controlled clinical trial of patients with solid tumours undergoing systemic cancer therapy with need of a follow-up visit with their consulting physician at outpatient clinics. 66 patients were 1:1 randomised to receive either a standard in-person follow-up visit at outpatient clinics or a video call via a mobile phone application. The primary outcome was feasibility defined as the proportion of patients successfully completing the first follow-up visit. Secondary outcomes included success rate of further video calls, time spent by patient and physician, patient satisfaction and quality of physician–patient relationship.FindingsSuccess rate of the first follow-up visit in the intention-to-treat cohort was 87.9% (29 of 33) for in-person visits and 78.8% (26 of 33) for video calls (relative risk: RR 0.90, 95% CI 0.70 to 1.13, p=0.51). The most common reasons for failure were software incompatibility in the video call and no-show in the in-person visit arm. The success rate for further video visits was 91.7% (11 of 12). Standardised patient questionnaires showed significantly decreased total time spent and less direct costs for patients (Δmean −170.8 min, 95% CI −246 min to −95.5 min), p<0.0001; Δmean −€14.37, 95% CI −€23.9 to −€4.8, p<0.005) and comparable time spent for physicians in the video call arm (Δmean 0.5 min, 95% CI −5.4 min to 6.4 min, p=0.86). Physician–patient relationship quality mean scores assessed by a validated standardised questionnaire were higher in the video call arm (1.13-fold, p=0.02).InterpretationFollow-up visits with the tested mobile phone video call application were feasible but software compatibility should be critically evaluated.Trial registration numberDRKS00015788.

show abstract

Section: Discussionsupporting

confidence: 85%

Completion rate and impact on physician–patient relationship of video consultations in medical oncology: a randomised controlled open-label trial

et al. 2020

View full text Add to dashboard Cite

show abstract

“…To fully understanding the impact of SARS‐CoV‐2 on the nervous system, it is essential that documentation of all neurological symptoms is collected for patients infected with the disease, so that further analysis can be performed into neurological manifestations. An aspect of SARS‐CoV‐2, not yet fully understood, is the long‐term sequelae the virus may have on different systems of the body 47‐50 . Again, detailed documentation and long‐term follow‐up of recovered SARS‐CoV‐2 patients will allow conclusions to be drawn on this area.…”

Section: Resultsmentioning

confidence: 99%

Neurological Manifestations of COVID‐19: A systematic review and current update

2020

Self Cite

View full text Add to dashboard Cite

The novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2), was first identified in December of 2019 in the city of Wuhan, China. Since the outbreak, various reports detail its symptoms and outcomes, primarily focusing on respiratory complications. However, reports are emerging of the virus’ effects systemically, including that of the nervous system. A review of all current published literature was conducted, and we report that headache and anosmia were common neurological manifestations of SARS‐CoV‐2. Less common symptoms include seizure, stroke and isolated cases of Guillain‐Barre syndrome. Further research is now warranted to precisely determine the relationship between those patients developing neurological sequelae, their clinical state and any subsequent morbidity and mortality.

show abstract

“…The COVID-19 work pattern established technology at the heart of the delivery of care where virtual clinics using telephone and video consultation will be a long-lasting legacy and MDTs and meetings using video conferencing will be the norm. 13 The use of these communication technologies was positively received by healthcare workers and patients. However, it also highlighted the need to develop a communication infrastructure to ensure that these services can be delivered to all parts of the community regardless of geographic or economic background.…”

Section: Discussionmentioning

confidence: 99%

The impact of the COVID-19 pandemic on cardiology services

et al. 2020

View full text Add to dashboard Cite

ObjectiveThe COVID-19 pandemic resulted in prioritisation of National Health Service (NHS) resources to cope with the surge in infected patients. However, there have been no studies in the UK looking at the effect of the COVID-19 work pattern on the provision of cardiology services. We aimed to assess the impact of the pandemic on cardiology services and clinical activity.MethodsWe analysed key performance indicators in cardiology services in a single centre in the UK in the periods prior to and during lockdown to assess reduction or changes in service provision.ResultsThere has been a greater than 50% drop in the number of patients presenting to cardiology and those diagnosed with myocardial infarction. All areas of cardiology service provision sustained significant reductions, which included outpatient clinics, investigations, procedures and cardiology community services such as heart failure and cardiac rehabilitation.ConclusionsAs ischaemic heart disease continues to be the leading cause of death nationally and globally, cardiology services need to prepare for a significant increase in workload in the recovery phase and develop new pathways to urgently help those adversely affected by the changes in service provision.

show abstract

Cancer Patient Care during COVID-19

Cited by 56 publications

References 10 publications

Completion rate and impact on physician–patient relationship of video consultations in medical oncology: a randomised controlled open-label trial

Completion rate and impact on physician–patient relationship of video consultations in medical oncology: a randomised controlled open-label trial

Neurological Manifestations of COVID‐19: A systematic review and current update

The impact of the COVID-19 pandemic on cardiology services

Contact Info

Product

Resources

About